Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT03391466 |
Title | A Study Evaluating the Efficacy of Axicabtagene Ciloleucel Compared to Standard of Care Therapy in Subjects With Relapsed/Refractory Diffuse Large B Cell Lymphoma (ZUMA-7) |
Acronym | ZUMA-7 |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase III |
Variant Requirements | No |
Sponsors | Kite, A Gilead Company |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | SWE | NLD | ITA | ISR | GBR | FRA | ESP | DEU | CHE | CAN | BEL | AUT | AUS |